Cargando…

Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases

MOG-antibody associated disease (MOG-AAD) is a recently recognized demyelinating disorder predominantly affecting children but also occurs in adults, with a relapsing course in approximately 50% of patients. We evaluated peripheral blood mononuclear cells from MOG-AAD patients by flow cytometry and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saxena, Shrishti, Lokhande, Hrishikesh, Gombolay, Grace, Raheja, Radhika, Rooney, Timothy, Chitnis, Tanuja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381621/ https://www.ncbi.nlm.nih.gov/pubmed/32709905 http://dx.doi.org/10.1038/s41598-020-69182-w

Ejemplares similares

Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4
por: Pandit, Lekha, et al.
Publicado: (2020)

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod
por: Gonzalez-Martinez, Alicia, et al.
Publicado: (2023)

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study
por: Gonzalez-Martinez, Alicia, et al.
Publicado: (2023)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
por: Manzano, Giovanna S., et al.
Publicado: (2022)

Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability
por: Sotiropoulos, Marinos G, et al.
Publicado: (2021)

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
por: Horellou, Philippe, et al.
Publicado: (2021)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Neurological update: MOG antibody disease
por: Wynford-Thomas, Ray, et al.
Publicado: (2018)

Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS
por: Lokhande, Hrishikesh, et al.
Publicado: (2022)

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

Understanding MOG antibody-associated disease in Brazil
por: Callegaro, Dagoberto, et al.
Publicado: (2023)

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity
por: Bose, Gauruv, et al.
Publicado: (2023)

Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
por: Pöllinger, Bernadette, et al.
Publicado: (2009)

Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects
por: Chitnis, Tanuja, et al.
Publicado: (2022)

microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance
por: Fujiwara, Mai, et al.
Publicado: (2022)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Antigen-specific immunotherapy for MOG antibody-associated diseases
por: Nessler, Stefan
Publicado: (2019)

Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study
por: Zhao, Yijun, et al.
Publicado: (2020)

Author Correction: Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study
por: Zhao, Yijun, et al.
Publicado: (2020)

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
por: Regev, Keren, et al.
Publicado: (2016)

Relapsing Anti-MOG Antibody-associated Disease following COVID-19 Vaccination: A Rare Case Report and Review of the Literature
por: Nakano, Hiroto, et al.
Publicado: (2022)

Cranial nerve involvement in patients with MOG antibody–associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
por: Wegener-Panzer, Andreas, et al.
Publicado: (2020)

Clinical characteristics of MOG antibody disease: two case reports
por: Guan, Yujia, et al.
Publicado: (2021)

No strong HLA association with MOG antibody disease in the UK population
por: Grant‐Peters, Melissa, et al.
Publicado: (2021)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Investigating the association between neoplasms and MOG antibody-associated disease
por: Trentinaglia, Milena, et al.
Publicado: (2023)

TNFAIP8 variants as potential epidemiological and predictive biomarkers in ovarian cancer
por: Gao, Hongyu, et al.
Publicado: (2020)

Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis
por: Healy, Brian C., et al.
Publicado: (2013)

Identification of TNFAIP8 as an Immune-Related Biomarker Associated With Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
por: Sun, Yuliang, et al.
Publicado: (2021)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Susceptibility of TNFAIP8, TNFAIP8L1, and TNFAIP2 Gene Polymorphisms on Cancer Risk: A Comprehensive Review and Meta-Analysis of Case–Control Studies
por: Bhowmik, Khokon Kanti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5pdo09ip24i95bvu914rcijcfs